PanCAN Scientific Summit 2022

5:30 p.m. — 6:30 p.m.

PanCAN Scientific and Medical Advisory Board Reception (closed, invite only)

Republic Ballroom A

6:30 p.m. — 9:30 p.m.

General Reception

Republic Ballroom B

Welcome Remarks

Julie Fleshman, JD, MBA, PanCAN President and CEO

Poster Session
2021 Class of Career Development Awards and Fellowships

Evaluation of Antitumor Immunity in Human Clinical Trials
Victoire Cardot-Ruffino, PhD, Dana-Farber Cancer Institute
Grant Funded by The Francois Wallace Monahan Fund in memory of Michael Insel

Preclinical Evaluation of Netrin-1 Antibody for Treatment of Pancreatic Cancer
Charline Ogier, PhD, Fox Chase Cancer Center
Grant funded by The Francois Wallace Monahan Fund in memory of Michael Insel

Hnf1b Defines an Epigenetic Ontology of Human Pancreatic Cancer
Rohit Chandwani, MD, PhD, Weill Cornell Medicine
Grant funded by The Jim & Shirley Young Family Foundation

Metabolic Link to Immunosuppressive Fibroblasts in Pancreatic Cancer
Ralph Francescone, PhD, Fox Chase Cancer Center
Grant funded in memory of Skip Viragh

Targeting BARD1 in Pancreatic Ductal Adenocarcinoma
Aditi Jain, PhD, Thomas Jefferson University

Dissecting Malignant Evolution Unleashed by p53 Inactivation in PDAC
John Morris IV, PhD, University of North Carolina at Chapel Hill
Grant funded in memory of Skip Viragh

Developing Engineered Proteins to Enhance Adoptive Cell Therapy of PDA
Shannon Oda, PhD, Seattle Children's Research Institute
Grant funded by Linda E. Amuso in memory of Susan A. Lombardi

PanCAN Posters Featured at the American Association for Cancer Research Special Conference: Pancreatic Cancer

PanCAN's SPARK: A cloud-based health data integration platform for pancreatic cancer
Kawther Abdilleh, PhD, Associate Director, Health Data Analytics, PanCAN

Patients with pancreatic cancer reporting prediagnosis pain have greater pain intensity scores, symptom burden, and ER visits: need for improved, ongoing management in pancreatic pain and associated symptoms
Terry McNearney, PhD, Consultant, PanCAN
Lynn Matrisian, PhD, MBA, Chief Science Officer, PanCAN

The Early Detection Initiative trial version 2: A platform trial to test novel approaches to pancreatic cancer screening in patients with new onset hyperglycemia and diabetes
Eva Shrader, MS, CCRP, Senior Director, Scientific Initiatives, PanCAN

7:30 a.m. — 8:30 a.m.

Breakfast

Republic Ballroom

8:30 a.m. — 3:30 p.m.

Scientific Sessions

Constitution Ballroom

8:30 a.m. — 8:35 a.m.

Community for Progress and 2022 Scientific Summit Overview

Margaret Tempero, MD, University of California, San Francisco Chair, PanCAN Scientific and Medical Advisory Board

8:35 a.m. — 8:55 a.m.

PanCAN State of the Union and Welcome 2022 Class of Grantees

Julie Fleshman, JD, MBA

8:55 a.m. — 9:50 a.m.

Early Detection

Session Facilitator: Lynn Matrisian, PhD, MBA, PanCAN Chief Science Officer

9:50 a.m. — 10:00 a.m.

Break

10:00 a.m. — 11:40 a.m.

Career Development Awards

11:40 a.m. — 12:00 p.m.

Research Acceleration Network Grant

Eliminating T Cell Barriers in Pancreatic Cancer Patients
Steven Leach, MD, Dartmouth College
Grant funded by Celgene Corporation

12:00 p.m. — 12:50 p.m.

Lunch

Republic Ballroom

12:50 p.m. — 1:00 p.m.

Industry Member Interlude

1:00 p.m. — 2:00 p.m.

Translational Research Grants

2:00 p.m. — 2:10 p.m.

PanCAN SPARK Health Data Platform

Sudheer Doss, PhD, PanCAN Chief Business Officer
Kawther Abdilleh, PhD, PanCAN Associate Director, Health Data Analytics

2:10 p.m. — 3:15 p.m.

PanCAN Precision Promise

Session Facilitator: Diane Simeone, MD, NYU Langone Health Chair, Precision Promise Steering Committee

2:55 p.m. — 3:15 p.m.

Therapeutic Accelerator Award

Phase 1/2 Trial of VS-6766 + Defactinib and GEM + Nab-P in metastatic PDAC
Louis Denis, MD, and Jonathan Pachter, PhD, Verastem Oncology, Inc.
Grant supported by the 1440 Foundation and the Gail V. Coleman-Kenneth M. Bruntel Research Fund

3:15 p.m. — 3:30 p.m.

Closing Remarks

Margaret Tempero, MD
Julie Fleshman, JD, MBA